Cellular Origins, a company focused on enabling scalable, cost-effective, and efficient robotic manufacture of cell and gene therapies (CGTs), the Cell and Gene Therapy Catapult (CGT Catapult), an independent organization specializing in the advancement of the cell and gene therapy industry, and Resolution Therapeutics, a clinical-stage biopharmaceutical company pioneering regenerative macrophage therapy to treat inflammatory and fibrotic diseases, have formed a consortium funded by a cross-indu...